By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NanoViricides, Inc. 

135 Wood Street, Suite 205

West Haven  Connecticut  06516  U.S.A.
Phone: n/a Fax:


Company News
NanoViricides, Inc. (NNVC.PK) Issued Registered Shares As Interest To Certain Debenture Holders 3/9/2015 7:00:01 AM
NanoViricides, Inc. (NNVC.PK) Files Quarterly Report For Period Ending 2014-12-31 2/25/2015 9:35:31 AM
NanoViricides, Inc. (NNVC.PK) Announces That A Research Report On The Company Has Been Published By Midtown Partners, Inc., A New York Investment Bank 2/17/2015 1:13:17 PM
NanoViricides, Inc. (NNVC.PK) Reports That The FluCide™ Candidate Was Found To Be Very Safe In Cglp-Like Safety And Toxicology Study In Rats Performed By Basi 1/23/2015 10:12:47 AM
NanoViricides, Inc. (NNVC.PK) Reports That It Has Shipped anti-Ebola Drug Candidates For Testing to a BSL-4 Hi-Security Biocontainment Laboratory 1/22/2015 10:24:46 AM
NanoViricides, Inc. (NNVC.PK)'s Executive Officers Report Insider Purchases Of Common Stock 1/21/2015 8:19:02 AM
NanoViricides, Inc. (NNVC.PK) Completes Purchase Of cGMP-compliant Pilot Production Facility 1/7/2015 7:58:00 AM
NanoViricides, Inc. (NNVC.PK) Says Injectable FluCide™ Selected In Top Ten Project To Watch - Presentation Today At The Therapeutics Area Partnerships Meeting In Boston 11/20/2014 1:53:54 PM
NanoViricides, Inc. (NNVC.PK) CEO, Eugene Seymour, MD, MPH, Invited To Discuss The Current Ebola Outbreak On Fox Business News At 9PM EDT Tonight 11/18/2014 4:33:00 PM
NanoViricides, Inc. (NNVC.PK) Files Quarterly Report - Reports Further Improved Strong Cash Position Sufficient For Clinical Trials Of Its First Two Drug Candidates 11/17/2014 4:27:07 PM